BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office

Stock News

2025/11/27

BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the "Tonghe Area Land Reserve Implementation Plan." On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.

According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the "clean land" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1160975531"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160975531\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160975531?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 19:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160975531","market":"sg","top_or_hot":-1,"title":"BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office","media":"Stock News","content":"<p>BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.</p>\n<p>According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAIYUNSHAN PH (00874): Guanghua Pharmaceutical Signs Land Reserve Compensation Agreement with Tonghe Subdistrict Office\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-27 19:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.</p>\n<p>According to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"","article_id":"1160975531","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160975531","pubTimestamp":1764242442,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600332":"白云山","BK0028":"国家队","BK1606":"中医药概念","BK1191":"制药","00874":"白云山","BK0175":"白马股","BK1515":"抗疫概念","BK0070":"员工持股","BK1574":"生物医药B类股","BK0196":"行业龙头","BK0097":"医药电商","BK0239":"医药制造","01477":"欧康维视生物-B","BK1197":"保健护理产品经销商","BK0096":"民营医院","BK1521":"挪威政府全球养老基金持仓","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念"},"translate_title":"白云山PH(00874)：光华药业与同和街道办事处签订土地储备补偿协议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":1,"01477":1,"00874":1},"content_text":"BAIYUNSHAN PH (00874) announced that its subsidiary, Guanghua Pharmaceutical, has a land parcel and fixed assets located at No. 355 Shatai North Road, Baiyun District, Guangzhou, included in the proposed land reserve scope under the \"Tonghe Area Land Reserve Implementation Plan.\" On November 27, 2025, Guanghua Pharmaceutical signed a land reserve compensation agreement with the Tonghe Subdistrict Office.\nAccording to the agreement, the compensation for the land reserve amounts to RMB 375 million. Upon meeting the \"clean land\" standard and other conditions, Guanghua Pharmaceutical will receive an additional land handover incentive of approximately RMB 73.3238 million. The total compensation and incentive amount to approximately RMB 449 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}